Coherus Oncology, Inc. (FRA:8C5)
1.040
+0.055 (5.63%)
At close: Dec 4, 2025
-47.97% (1Y)
| Market Cap | 127.49M |
| Revenue (ttm) | 236.71M |
| Net Income (ttm) | 132.08M |
| Shares Out | n/a |
| EPS (ttm) | 1.14 |
| PE Ratio | 0.97 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 455 |
| Open | 1.040 |
| Previous Close | 0.985 |
| Day's Range | 1.040 - 1.040 |
| 52-Week Range | 0.608 - 1.803 |
| Beta | n/a |
| RSI | 42.71 |
| Earnings Date | Mar 4, 2026 |